- Home
- NSTS vs BRNS Comparison
NSTS vs BRNS Comparison
Compare NSTS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NSTS | BRNS |
|---|---|---|
| Founded | 1921 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NSTS | BRNS |
|---|---|---|
| Price | $12.15 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 7.6K | ★ 70.5K |
| Earning Date | 11-13-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,762,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 57.78 | ★ 1766.46 |
| 52 Week Low | $10.72 | $0.64 |
| 52 Week High | $13.32 | $2.92 |
Technical Indicators
Market Signals| Indicator | NSTS | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 72.71 | 43.33 |
| Support Level | $11.70 | $0.68 |
| Resistance Level | $12.31 | $0.78 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 65.51 | 58.02 |
Price Performance
Historical ComparisonAbout NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.